Endorcine Flashcards
(218 cards)
What is used to treat diabetes insipidus?
Vasopressin
What is desmopressin used for?
Nocturnal enuresis
Used to test fibrinolytic response
Used to treat mild-moderate haemophilia and VWD (a life-long bleeding disorder in which blood does not clot properly)
How do you treat hyponatraemia resulting from inappropriate secretion of antidiuretic hormone?
If fluid restriction alone does not restore sodium concentration or is not tolerable
- Treat with demeclocycline
- 2nd line: Tolvaptan
What would happen if rapid correction of hyponatraemia occurs during tolvaptan therapy?
Could cause osmotic demyelination leading to serious neurological events
- slowly monitor serum sodium concentration and balance fluid
Which drugs increase the secretion of vasopressin?
Tricyclic antidepressants = increases risk of hyponatraemia
What counselling is given for the treatment of nocturnal enuresis with desmopressin?
Hyponatraemic convulsions - avoid fluid overload (including during swimming) and stop taking drug during episodes of vomiting and diarrhoea until fluid balance normal
What is the risk associated with desmopressin and vasopressin in pregnancy?
oxytocic
How do you take tolvaptan?
Morning dose 30 minutes before food and second dose can be taken with or without food
What are the risk factors associated with osteoporosis?
Post-menopausal women
Men over 50
Patients taking long-term corticosteroids
What vitamins should patients with osteoporosis aim to increase?
Intake of calcium and vitamin D
How do you treat postmenopausal osteoporosis?
1st line: alendronic acid (10mg OD or 70mg weekly) or risedronate (5mg OD or 35mg weekly) due to broad spectrum of anti-fracture efficacy
Alternative - ibandronic acid
If intolerant of oral bisphosphonates = consider parenteral bisphosphonates or denosumab
More alternatives: raloxifene, strontium
HRT - restricted to younger postmenopausal women due to risk of adverse effects such as CVD and cancer
- Another option in younger women is tibolone
What is used in menopausal women at severe risk of osteoporosis at high risk of fractures?
Teriparatide
Romosozumab - who have previously experienced a fragility fracture and are at imminent risk of another (within 24 months)
Who should be considered for bone-protection treatment for patients who have glucocorticoid-induced osteoporosis?
Women:
- aged ≥ 70 OR
- had previous fragility fracture OR
- taking large doses of glucocorticoids (prednisolone ≥ 7.5mg daily or equivalent)
Men:
- aged ≥ 70 with a previous fragility fracture OR
- taking large doses of glucocorticoids
All men and women taking large doses of glucocorticoids (≥ 7.5mg daily prednisolone or equivalent) for 3 months or longer
What is the treatment for bone protection?
1st line: alendronic acid/ risedronate
If intolerant to oral bisphosphonates or unsuitable
- zoledronic acid
- denosumab
- teriparatide
How do you treat osteoporosis in men?
1st line: alendronic acid (10mg OD) or risedronate (35mg weekly)
2nd line: zoledronic acid or denosumab
3rd line: teriparatide or strontium
How long is the duration of biphosphonate treatment?
Reviewed after 5 years with alendronic acid, risedronate and ibandronic acid
Reviewed after 3 years with zoledronic acid
Continuation beyond this period recommended for patients over 70, have a history of previous hip or vertebral fractures, had 1 or more fragility fractures during treatment, or who are taking long-term glucocorticoid therapy
What are the MHRA warnings for biphosphonates?
- Atypical femoral fractures: report any thigh, hip or groin pain during treatment
- Osteonecrosis of the jaw: (most potent bisphosphonates = zoledronic acid) get regular dental check-ups and good oral hygiene
- Osteonecrosis of the auditory canal: report any ear pain, discharge from the ear or an ear infection during treatment
What are the common side effects of alendronic acid?
GI disorders
Joint swelling
Vertigo
Skin reactions
When should you avoid alendronic acid in renal impairment?
If CrCl less than 35ml/min
What is the caution for strontium?
Risk factors for CVD - assess every 6-12 months during treatment
Risk factors for VTE - discontinue in patients who become immobile
What are the MHRA warnings associated with denosumab?
- atypical femoral fractures
- osteonecrosis of the jaw
- osteonecrosis of the auditory canal
- rebound hypercalcemia up to 9 months after discontinuation of treatment for giant cell tumour of bone
- vertebral fractures after stopping (up to 18 months) or delaying ongoing treatment (60mg)
- do not use in under 18 due to severe risk of hypercalaemis
What corticosteroid is used for postural hypotension in autonomic neuropathy?
Fludrocortisone - mineralcorticoid activity
What corticosteroids are used for congenital adrenal hyperplasia?
Dexamethasone and betamethasone - glucocorticoid activity (long-acting)
What corticosteroid do you use to test for Cushing’s syndrome?
overnight dexamethasone suppression test